好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2024 Annual Meeting | C134 - Coding Update: Turning Coding into Dollars and Sense

Tuesday 04/16/24
03:30 PM - 05:30 PM MDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Brian T. Cabaniss, MD
Practice, Policy, and Ethics
Participants should become familiar with high-yield recent topics in coding to help them get reimbursed for the work they are doing, including an overview and key concepts from the 2021 Outpatient E/M changes, the 2023 Inpatient E/M changes, Critical Care, non-face-to-face codes, and important new codes and rules for 2024 (changes to split/shared billing and G2211 add-on code).
2.00 CME credits
Systems-based Practice
Intermediate
Advanced Practice Provider
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Business Administrator
Case-based, Didactic

Program Evaluations

Event Timeline
03:30 PM - 03:35 PM MDT Speaker Introduction
Brian T. Cabaniss, MD
03:35 PM - 03:55 PM MDT Speaker Outpatient E/M, G2211
Brian T. Cabaniss, MD
03:55 PM - 04:25 PM MDT Speaker Inpatient E/M, Critical Care E/M, Split-shared Billing
Sayona John, MD, FAAN
04:25 PM - 04:55 PM MDT Speaker Non-face-to-face Codes, Miscellaneous
Gabriela De Bruin, MD
04:55 PM - 05:30 PM MDT Q&A Questions & Answers
Brian T. Cabaniss, MD, Sayona John, MD, FAAN, Gabriela De Bruin, MD
Faculty Disclosures
Sayona John, MD, FAAN Dr. John has nothing to disclose.
Gabriela De Bruin, MD An immediate family member of Dr. De Bruin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. De Bruin has stock in Neuroquestions LLC. An immediate family member of Dr. De Bruin has stock in Neuroquestions LLC.
Brian T. Cabaniss, MD The institution of Dr. Cabaniss has received research support from Medtronic. The institution of Dr. Cabaniss has received research support from Takeda Pharmaceuticals.